BioTalk

This article is part of a series on the final agreement reached regarding the pharmaceutical package, which is currently awaiting formal...

The EU regulatory landscape for medical devices making use of artificial intelligence (MDAI) has become significantly more complex with...

Following the EC’s announcement of the European Pharmaceutical Strategy[1], the Polish government and the country’s business associations...